vs

Side-by-side financial comparison of CareTrust REIT, Inc. (CTRE) and SunOpta Inc. (STKL). Click either name above to swap in a different company.

SunOpta Inc. is the larger business by last-quarter revenue ($205.4M vs $134.9M, roughly 1.5× CareTrust REIT, Inc.). CareTrust REIT, Inc. runs the higher net margin — 82.5% vs 0.4%, a 82.1% gap on every dollar of revenue. On growth, CareTrust REIT, Inc. posted the faster year-over-year revenue change (55.1% vs 16.6%). Over the past eight quarters, CareTrust REIT, Inc.'s revenue compounded faster (46.2% CAGR vs 7.4%).

Target Healthcare REIT is a British property investment company which invests in healthcare properties and holds a large portfolio of care homes. It is structured as a real estate investment trust (REIT) and is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

SunOpta, Inc. is a multi-national food and mineral company headquartered in Eden Prairie, Minnesota and founded in 1973 in Canada.

CTRE vs STKL — Head-to-Head

Bigger by revenue
STKL
STKL
1.5× larger
STKL
$205.4M
$134.9M
CTRE
Growing faster (revenue YoY)
CTRE
CTRE
+38.5% gap
CTRE
55.1%
16.6%
STKL
Higher net margin
CTRE
CTRE
82.1% more per $
CTRE
82.5%
0.4%
STKL
Faster 2-yr revenue CAGR
CTRE
CTRE
Annualised
CTRE
46.2%
7.4%
STKL

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CTRE
CTRE
STKL
STKL
Revenue
$134.9M
$205.4M
Net Profit
$111.3M
$816.0K
Gross Margin
12.4%
Operating Margin
3.3%
Net Margin
82.5%
0.4%
Revenue YoY
55.1%
16.6%
Net Profit YoY
113.5%
113.1%
EPS (diluted)
$0.52
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTRE
CTRE
STKL
STKL
Q4 25
$134.9M
Q3 25
$132.4M
$205.4M
Q2 25
$112.5M
$191.5M
Q1 25
$96.6M
$201.6M
Q4 24
$86.9M
$193.9M
Q3 24
$77.4M
$175.9M
Q2 24
$68.9M
$169.5M
Q1 24
$63.1M
$184.4M
Net Profit
CTRE
CTRE
STKL
STKL
Q4 25
$111.3M
Q3 25
$74.9M
$816.0K
Q2 25
$68.5M
$4.4M
Q1 25
$65.8M
$4.8M
Q4 24
$52.1M
$-8.7M
Q3 24
$33.4M
$-6.2M
Q2 24
$10.8M
$-5.3M
Q1 24
$28.7M
$2.9M
Gross Margin
CTRE
CTRE
STKL
STKL
Q4 25
Q3 25
12.4%
Q2 25
14.8%
Q1 25
15.0%
Q4 24
10.9%
Q3 24
13.0%
Q2 24
12.5%
Q1 24
16.8%
Operating Margin
CTRE
CTRE
STKL
STKL
Q4 25
Q3 25
58.1%
3.3%
Q2 25
61.3%
5.5%
Q1 25
5.2%
Q4 24
1.4%
Q3 24
43.0%
0.5%
Q2 24
15.1%
1.2%
Q1 24
5.5%
Net Margin
CTRE
CTRE
STKL
STKL
Q4 25
82.5%
Q3 25
56.6%
0.4%
Q2 25
60.9%
2.3%
Q1 25
68.1%
2.4%
Q4 24
60.0%
-4.5%
Q3 24
43.2%
-3.5%
Q2 24
15.6%
-3.1%
Q1 24
45.6%
1.6%
EPS (diluted)
CTRE
CTRE
STKL
STKL
Q4 25
$0.52
Q3 25
$0.35
$0.01
Q2 25
$0.35
$0.03
Q1 25
$0.35
$0.04
Q4 24
$0.30
$-0.08
Q3 24
$0.21
$-0.05
Q2 24
$0.07
$-0.04
Q1 24
$0.22
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTRE
CTRE
STKL
STKL
Cash + ST InvestmentsLiquidity on hand
$198.0M
$2.2M
Total DebtLower is stronger
$894.2M
$250.8M
Stockholders' EquityBook value
$4.0B
$162.8M
Total Assets
$5.1B
$694.1M
Debt / EquityLower = less leverage
0.22×
1.54×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTRE
CTRE
STKL
STKL
Q4 25
$198.0M
Q3 25
$712.5M
$2.2M
Q2 25
$306.1M
$2.2M
Q1 25
$26.5M
$2.3M
Q4 24
$213.8M
$1.6M
Q3 24
$377.1M
$2.9M
Q2 24
$495.1M
$3.2M
Q1 24
$451.2M
$1.5M
Total Debt
CTRE
CTRE
STKL
STKL
Q4 25
$894.2M
Q3 25
$893.8M
$250.8M
Q2 25
$1.2B
$263.3M
Q1 25
$822.1M
$260.6M
Q4 24
$396.9M
$265.2M
Q3 24
$396.7M
$289.9M
Q2 24
$671.1M
$303.1M
Q1 24
$595.9M
$258.8M
Stockholders' Equity
CTRE
CTRE
STKL
STKL
Q4 25
$4.0B
Q3 25
$4.0B
$162.8M
Q2 25
$3.3B
$159.8M
Q1 25
$2.9B
$154.8M
Q4 24
$2.9B
$148.6M
Q3 24
$2.4B
$155.0M
Q2 24
$1.9B
$158.8M
Q1 24
$1.7B
$163.6M
Total Assets
CTRE
CTRE
STKL
STKL
Q4 25
$5.1B
Q3 25
$5.1B
$694.1M
Q2 25
$4.7B
$704.9M
Q1 25
$3.9B
$690.7M
Q4 24
$3.4B
$668.5M
Q3 24
$2.9B
$699.3M
Q2 24
$2.7B
$704.7M
Q1 24
$2.3B
$671.8M
Debt / Equity
CTRE
CTRE
STKL
STKL
Q4 25
0.22×
Q3 25
0.22×
1.54×
Q2 25
0.35×
1.65×
Q1 25
0.28×
1.68×
Q4 24
0.14×
1.78×
Q3 24
0.16×
1.87×
Q2 24
0.35×
1.91×
Q1 24
0.36×
1.58×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTRE
CTRE
STKL
STKL
Operating Cash FlowLast quarter
$394.0M
$16.3M
Free Cash FlowOCF − Capex
$12.1M
FCF MarginFCF / Revenue
5.9%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
3.54×
20.03×
TTM Free Cash FlowTrailing 4 quarters
$36.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTRE
CTRE
STKL
STKL
Q4 25
$394.0M
Q3 25
$100.9M
$16.3M
Q2 25
$100.8M
$-4.5M
Q1 25
$71.4M
$22.3M
Q4 24
$244.3M
$33.1M
Q3 24
$67.2M
$17.2M
Q2 24
$53.0M
$-5.6M
Q1 24
$48.8M
$5.3M
Free Cash Flow
CTRE
CTRE
STKL
STKL
Q4 25
Q3 25
$12.1M
Q2 25
$-9.2M
Q1 25
$9.5M
Q4 24
$24.0M
Q3 24
$11.7M
Q2 24
$-15.3M
Q1 24
$-2.3M
FCF Margin
CTRE
CTRE
STKL
STKL
Q4 25
Q3 25
5.9%
Q2 25
-4.8%
Q1 25
4.7%
Q4 24
12.4%
Q3 24
6.6%
Q2 24
-9.0%
Q1 24
-1.2%
Capex Intensity
CTRE
CTRE
STKL
STKL
Q4 25
Q3 25
2.1%
Q2 25
2.5%
Q1 25
6.3%
Q4 24
4.7%
Q3 24
3.2%
Q2 24
5.7%
Q1 24
4.1%
Cash Conversion
CTRE
CTRE
STKL
STKL
Q4 25
3.54×
Q3 25
1.35×
20.03×
Q2 25
1.47×
-1.03×
Q1 25
1.08×
4.63×
Q4 24
4.68×
Q3 24
2.01×
Q2 24
4.92×
Q1 24
1.70×
1.83×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTRE
CTRE

Segment breakdown not available.

STKL
STKL

Beverages And Broths$161.4M79%
Fruit Snacks$40.9M20%
Ingredients$3.1M2%

Related Comparisons